Kiadis Pharma to present at upcoming investor conferences in March 2019
March 01, 2019 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to present at upcoming investor conferences in March 2019 Amsterdam, The Netherlands, March 1, 2019 - Kiadis Pharma N.V. ("Kiadis...
Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders
February 15, 2019 14:06 ET
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, 15 February 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and...
Kiadis Pharma to participate in a panel at Innovation for Health 2019
February 11, 2019 11:45 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to participate in a panel at Innovation for Health 2019 Amsterdam, The Netherlands, February 11, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam...
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer
February 04, 2019 11:45 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer Amsterdam, The Netherlands, and Boston, Massachusetts, USA...
Kiadis Pharma expands presence in the United States
January 04, 2019 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma expands presence in the United States Scott Holmes commences position as chief financial officerAmy Sullivan appointed senior vice...
Kiadis Pharma to present at Biotech Showcase 2019
January 03, 2019 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to present at Biotech Showcase 2019 Amsterdam, The Netherlands, January 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a...
Kiadis Pharma to present at upcoming investor conferences in November 2018
November 13, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to present at upcoming investor conferences in November 2018 Amsterdam, The Netherlands, November 13, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext...
Kiadis Pharma strengthens core team with three senior appointments
November 08, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, November 8, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage...
Kiadis Pharma N. V.: Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting
November 07, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting Amsterdam,...
Kiadis Pharma raises €31.2 million in a private placement of 3.9 million new shares
October 19, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...